Marken James G.
SEC CIK 1579587 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANIP | ANI PHARMACEUTICALS INC | SVP OPS, PROD DEV | 123.6K | — | $2.54M | 22 | 2022-03-23 | 2024-06-07 |
Most active insiders at ANIP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lalwani Nikhil | Pres, CEO, Dir | — | $5.05M |
| 2 | Walsh Patrick D | Dir | — | $2.32M |
| 3 | CAREY STEPHEN P. | SVP, CFO | — | $1.78M |
| 4 | Mutz Christopher | HEAD OF RARE DISEASE | — | $1.64M |
| 5 | Gassert Chad | SVP - CORP. DEV, STRATEGY | — | $1.31M |
| 6 | Davis Krista | SVP, Chief HR Off | — | $918.6K |
| 7 | Gutwerg Ori | SVP, GENERICS | — | $621.4K |
| 8 | Cook Meredith | SVP, GC, SEC | — | $453.9K |
| 9 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | — | $393.8K |
| 10 | HAUGHEY THOMAS | Dir | — | $161.8K |
Marken James G. made no open-market trades at ANIP in the last 12 months.
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-06-11 | 2024-06-07 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | M - OptEx | $52.70 | +12.6K | 123.6K | +11% | +$661.4K |
| D | 2024-06-11 | 2024-06-07 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | F - Tax | $67.70 | -11.1K | 117.8K | -9% | -$750.6K |
| 2024-04-11 | 2024-04-10 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | F - Tax | $66.96 | -2,799 | 116.0K | -2% | -$187.4K | |
| 2024-03-25 | 2024-03-23 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | F - Tax | $69.58 | -3,653 | 118.8K | -3% | -$254.2K | |
| 2024-03-07 | 2024-03-07 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | S - Sale | $66.37 | -24.3K | 124.5K | -16% | -$1.62M | |
| 2024-03-07 | 2024-03-07 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | F - Tax | $66.71 | -2,034 | 122.5K | -2% | -$135.7K | |
| 2024-03-01 | 2024-02-29 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | F - Tax | $67.67 | -1,058 | 148.8K | -0.7% | -$71.6K | |
| M | 2024-02-16 | 2024-02-14 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | A - Grant | $0.00 | +16.8K | 149.9K | +13% | $0 |
| DM | 2023-08-25 | 2023-08-23 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | M - OptEx | $38.25 | +5,417 | 135.4K | +4% | +$207.2K |
| D | 2023-08-25 | 2023-08-23 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | S - Sale+OE | $63.00 | -3,932 | 133.1K | -3% | -$247.7K |
| 2023-04-12 | 2023-04-10 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | F - Tax | $38.50 | -2,289 | 131.6K | -2% | -$88.1K | |
| M | 2023-04-04 | 2023-02-28 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | A - Grant | $0.00 | +21.7K | 133.9K | +19% | $0 |
| 2023-03-30 | 2023-03-28 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | F - Tax | $38.62 | -524 | 112.2K | -0.5% | -$20.2K | |
| 2023-03-27 | 2023-03-23 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | F - Tax | $37.82 | -2,452 | 112.7K | -2% | -$92.7K | |
| M | 2023-03-09 | 2023-03-07 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | F - Tax | $44.23 | -2,460 | 115.2K | -2% | -$108.8K |
| M | 2022-08-16 | 2022-08-12+ | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | S - Sale | $37.25 | -18.1K | 122.8K | -13% | -$673.0K |
| 2022-04-29 | 2022-04-27 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | A - Grant | $0.00 | +6,644 | 135.7K | +5% | $0 | |
| 2022-04-12 | 2022-04-10 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | F - Tax | $29.91 | -1,878 | 129.1K | -1% | -$56.2K | |
| 2022-04-08 | 2022-04-06 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | F - Tax | $29.69 | -337 | 130.9K | -0.3% | -$10.0K | |
| 2022-03-30 | 2022-03-28 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | F - Tax | $28.17 | -524 | 131.3K | -0.4% | -$14.8K | |
| 2022-03-28 | 2022-03-24 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | A - Grant | $0.00 | +19.9K | 131.8K | +18% | $0 | |
| 2022-03-25 | 2022-03-23 | ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS, PROD DEV | F - Tax | $27.03 | -2,452 | 111.9K | -2% | -$66.3K |
Purchase Sale Sale after option exercise All abbreviations